193 related articles for article (PubMed ID: 14624311)
1. In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances.
Ishii R; Shimizu M; Nakagawa Y; Shimizu K; Tanaka S; Takahashi H
Cancer Immunol Immunother; 2004 May; 53(5):383-90. PubMed ID: 14624311
[TBL] [Abstract][Full Text] [Related]
2. Suppression of murine tumour growth through CD8
Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
[TBL] [Abstract][Full Text] [Related]
3. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
Stober D; Jomantaite I; Schirmbeck R; Reimann J
J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
[TBL] [Abstract][Full Text] [Related]
4. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
[TBL] [Abstract][Full Text] [Related]
6. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of tumor-specific CD8⁺ CTLs by tumor-infiltrating tolerogenic dendritic cells.
Harimoto H; Shimizu M; Nakagawa Y; Nakatsuka K; Wakabayashi A; Sakamoto C; Takahashi H
Immunol Cell Biol; 2013 Oct; 91(9):545-55. PubMed ID: 24018532
[TBL] [Abstract][Full Text] [Related]
8. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
9. Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells.
Nakatsuka K; Sugiyama H; Nakagawa Y; Takahashi H
J Hepatol; 1999 Jun; 30(6):1119-29. PubMed ID: 10406192
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
Su H; Li B; Zheng L; Wang H; Zhang L
Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
[TBL] [Abstract][Full Text] [Related]
11. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
Petersen TR; Sika-Paotonu D; Knight DA; Simkins HM; Hermans IF
PLoS One; 2011 Mar; 6(3):e17657. PubMed ID: 21483862
[TBL] [Abstract][Full Text] [Related]
12. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
[TBL] [Abstract][Full Text] [Related]
13. CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity.
Li Y; Zhao C; Liu J; Lu Z; Lu M; Gu J; Liu R
Oncol Rep; 2019 May; 41(5):2679-2688. PubMed ID: 30864713
[TBL] [Abstract][Full Text] [Related]
14. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.
Joshi SK; Lang GA; Devera TS; Johnson AM; Kovats S; Lang ML
J Leukoc Biol; 2012 May; 91(5):783-90. PubMed ID: 22331103
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.
Ontiveros F; Wilson EB; Livingstone AM
Immunology; 2011 Apr; 132(4):549-58. PubMed ID: 21255009
[TBL] [Abstract][Full Text] [Related]
16. The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells.
Rubin B; Riond J; Courtiade L; Roullet N; Gairin JE
Cancer Immun; 2008 Sep; 8():14. PubMed ID: 18783178
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
[TBL] [Abstract][Full Text] [Related]
18. T cell development in mice expressing CD1d directed by a classical MHC class II promoter.
Forestier C; Park SH; Wei D; Benlagha K; Teyton L; Bendelac A
J Immunol; 2003 Oct; 171(8):4096-104. PubMed ID: 14530331
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
[TBL] [Abstract][Full Text] [Related]
20. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
